Profile | GDS5420 / 229396_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 2418.07 | 92 |
GSM1296119 | B_lesional_pre-dose | 739.27 | 74 |
GSM1296076 | C_lesional_pre-dose | 2217.65 | 89 |
GSM1296092 | D_lesional_pre-dose | 3514.55 | 95 |
GSM1296103 | E_lesional_pre-dose | 2659.66 | 92 |
GSM1296078 | F_lesional_pre-dose | 1911.67 | 88 |
GSM1296107 | G_lesional_pre-dose | 1977.66 | 89 |
GSM1296109 | H_lesional_pre-dose | 1868.81 | 89 |
GSM1296080 | I_lesional_pre-dose | 1272.85 | 82 |
GSM1296090 | J_lesional_pre-dose | 3010.81 | 93 |
GSM1296074 | K_lesional_pre-dose | 3591.96 | 94 |
GSM1296111 | L_lesional_pre-dose | 1951.99 | 89 |
GSM1296099 | M_lesional_pre-dose | 1779.98 | 88 |
GSM1296086 | O_lesional_pre-dose | 2260.76 | 90 |
GSM1296117 | P_lesional_pre-dose | 2232.25 | 91 |
GSM1296113 | Q_lesional_pre-dose | 2445.85 | 92 |
GSM1296096 | R_lesional_pre-dose | 3198.77 | 94 |
GSM1296105 | S_lesional_pre-dose | 979.27 | 79 |
GSM1296098 | T_lesional_pre-dose | 2199.98 | 91 |
GSM1296101 | U_lesional_pre-dose | 2023.23 | 89 |
GSM1296121 | V_lesional_pre-dose | 1673.87 | 87 |
GSM1296088 | W_lesional_pre-dose | 989.02 | 79 |
GSM1296082 | X_lesional_pre-dose | 3345.04 | 94 |
GSM1296115 | Y_lesional_pre-dose | 2571.49 | 92 |
GSM1296084 | Z_lesional_pre-dose | 1378.23 | 84 |
GSM1296072 | B_lesional_day8 | 606.83 | 71 |
GSM1296069 | L_lesional_day8 | 1078.98 | 81 |
GSM1296071 | P_lesional_day8 | 735.05 | 74 |
GSM1296070 | Y_lesional_day8 | 1959.47 | 90 |
GSM1296073 | V_lesional_day8 | 3323.07 | 94 |
GSM1296034 | A_lesional_day15 | 916.24 | 78 |
GSM1296041 | G_lesional_day15 | 2934.95 | 93 |
GSM1296035 | R_lesional_day15 | 3574.62 | 95 |
GSM1296038 | U_lesional_day15 | 1720.96 | 87 |
GSM1296047 | B_lesional_day15 | 304.79 | 59 |
GSM1296039 | E_lesional_day15 | 4153.56 | 95 |
GSM1296042 | H_lesional_day15 | 823.74 | 76 |
GSM1296043 | L_lesional_day15 | 1097.59 | 81 |
GSM1296037 | M_lesional_day15 | 485.08 | 67 |
GSM1296046 | P_lesional_day15 | 1533.37 | 86 |
GSM1296044 | Q_lesional_day15 | 1089.79 | 81 |
GSM1296045 | Y_lesional_day15 | 1603.29 | 87 |
GSM1296025 | C_lesional_day15 | 557.16 | 70 |
GSM1296033 | D_lesional_day15 | 1200.36 | 82 |
GSM1296027 | I_lesional_day15 | 556.4 | 70 |
GSM1296032 | J_lesional_day15 | 334.8 | 60 |
GSM1296024 | K_lesional_day15 | 539.42 | 69 |
GSM1296031 | W_lesional_day15 | 498.93 | 67 |
GSM1296028 | X_lesional_day15 | 630.67 | 71 |
GSM1296029 | Z_lesional_day15 | 761.97 | 74 |
GSM1296026 | F_lesional_day15 | 921.09 | 78 |
GSM1296030 | O_lesional_day15 | 1732.78 | 87 |
GSM1296040 | S_lesional_day15 | 2155.55 | 90 |
GSM1296036 | T_lesional_day15 | 1919.12 | 89 |
GSM1296048 | V_lesional_day15 | 2764.93 | 93 |
GSM1296059 | A_lesional_day43 | 2845.69 | 93 |
GSM1296066 | G_lesional_day43 | 2327.58 | 91 |
GSM1296060 | R_lesional_day43 | 2195.47 | 90 |
GSM1296063 | U_lesional_day43 | 3300.8 | 94 |
GSM1296064 | E_lesional_day43 | 4076.49 | 95 |
GSM1296067 | H_lesional_day43 | 504.09 | 67 |
GSM1296062 | M_lesional_day43 | 1235.18 | 82 |
GSM1296068 | Q_lesional_day43 | 864.44 | 77 |
GSM1296050 | C_lesional_day43 | 240.04 | 56 |
GSM1296057 | D_lesional_day43 | 941.44 | 78 |
GSM1296052 | I_lesional_day43 | 714.58 | 73 |
GSM1296054 | J_lesional_day43 | 535.97 | 68 |
GSM1296049 | K_lesional_day43 | 571.98 | 70 |
GSM1296055 | W_lesional_day43 | 418.21 | 64 |
GSM1296053 | X_lesional_day43 | 729.88 | 74 |
GSM1296058 | Z_lesional_day43 | 2308.17 | 91 |
GSM1296051 | F_lesional_day43 | 1087.57 | 80 |
GSM1296056 | O_lesional_day43 | 3676.04 | 95 |
GSM1296065 | S_lesional_day43 | 1721.17 | 87 |
GSM1296061 | T_lesional_day43 | 2007.32 | 90 |
GSM1296095 | A_non-lesional_pre-dose | 2947.33 | 93 |
GSM1296120 | B_non-lesional_pre-dose | 447.15 | 66 |
GSM1296077 | C_non-lesional_pre-dose | 488.54 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 854.19 | 76 |
GSM1296104 | E_non-lesional_pre-dose | 1235.46 | 82 |
GSM1296079 | F_non-lesional_pre-dose | 398.14 | 64 |
GSM1296108 | G_non-lesional_pre-dose | 1002.25 | 79 |
GSM1296110 | H_non-lesional_pre-dose | 816.84 | 76 |
GSM1296081 | I_non-lesional_pre-dose | 482.75 | 67 |
GSM1296091 | J_non-lesional_pre-dose | 2304.55 | 91 |
GSM1296075 | K_non-lesional_pre-dose | 978.08 | 79 |
GSM1296112 | L_non-lesional_pre-dose | 1552.88 | 87 |
GSM1296100 | M_non-lesional_pre-dose | 549.6 | 69 |
GSM1296087 | O_non-lesional_pre-dose | 1687.86 | 86 |
GSM1296118 | P_non-lesional_pre-dose | 449.53 | 65 |
GSM1296114 | Q_non-lesional_pre-dose | 1247.37 | 83 |
GSM1296097 | R_non-lesional_pre-dose | 1960.23 | 89 |
GSM1296106 | S_non-lesional_pre-dose | 1049.87 | 80 |
GSM1296102 | U_non-lesional_pre-dose | 1084.35 | 81 |
GSM1296122 | V_non-lesional_pre-dose | 304.82 | 59 |
GSM1296089 | W_non-lesional_pre-dose | 483.51 | 67 |
GSM1296083 | X_non-lesional_pre-dose | 552.59 | 69 |
GSM1296116 | Y_non-lesional_pre-dose | 1078.82 | 81 |
GSM1296085 | Z_non-lesional_pre-dose | 753.82 | 74 |